Use of alcohol and drugs among health professionals in Norway: A study using data from questionnaires and samples of oral fluid

Journal of Occupational Medicine and Toxicology

Volumn 9, Issue 1, 2014, Pages

  Edvardsen, Hilde Marie Erøy ^a   Karinen, Ritva ^a   Moan, Inger Synnøve ^b   Øiestad, Elisabeth Leere ^a   Christophersen, Asbjørg Solberg ^a   Gjerde, Hallvard ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b NORWEGIAN INSTITUTE FOR ALCOHOL AND DRUG RESEARCH   (Norway)

Author keywords

Ethanol; Illicit drugs; Medications; Prevalence; Psychoactive substances; Saliva; Self report; Workplace drug testing

Indexed keywords

7 AMINO 1,3 DIHYDRO 5 PHENYL 2H 1,4 BENZODIAZEPIN 2 ONE; 7 AMINOFLUNITRAZEPAM; ALCOHOL; ALPRAZOLAM; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; BENZOYLECGONINE; BUPRENORPHINE; CLONAZEPAM; COCAINE; CODEINE; DIAZEPAM; ETHYL GLUCURONIDE; FENTANYL; FLUNITRAZEPAM; ILLICIT DRUG; METHADONE; METHAMPHETAMINE; MORPHINE; MORPHINE 6 ACETATE; NITRAZEPAM; NORDAZEPAM; OPIATE; OXAZEPAM; OXYCODONE; PHENAZEPAM; TETRAHYDROCANNABINOL; TRAMADOL; ZOLPIDEM; ZOPICLONE;

ABSENTEEISM; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; DRUG USE; FEMALE; HANGOVER; HEALTH PRACTITIONER; HUMAN; MALE; MIDDLE AGED; NORWAY; PREVALENCE; PRODUCTIVITY; QUESTIONNAIRE; SELF CONCEPT;

EID: 84898008834     PISSN: None     EISSN: 17456673     Source Type: Journal    
DOI: 10.1186/1745-6673-9-8     Document Type: Article

References (33)

1. The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. Rehm J, Gnam W, Popova S, Baliunas D, Brochu S, Fischer B, Patra J, Sarnocinska-Hart A, Taylor B, J Stud Alcohol Drugs 2007 68 6 886 895 17960307
2. Substance Abuse and Mental Health Services Administration, The NSDUH Report: Worker Substance Use, by Industry Category Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies 2007 [ http://www.samhsa.gov/data/2k7/industry/worker.pdf ]
3. Effects of drugs on human performance. Raes E, Verstraete A, Workplace Drug Testing. Volume 1 London: Pharmaceutical Press, Verstraete A, 2011 35 69
4. Per capita alcohol consumption and sickness absence in Norway. Norström T, Moan I, Eur J Publ Health 2009 19 4 383 388 10.1093/eurpub/ckp044
5. Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection and prevention. Berge K, Dillon K, Sikkink K, Taylor T, Lanier W, Mayo Clin Proc 2012 87 7 674 682 10.1016/j.mayocp.2012.03.013 22766087
6. Alcohol and Drug Abuse-the most Important Causes of Loss of Authorization. Norwegian Board of Health, Annual Supervision Report 2004 Oslo: Norwegian Board of Health, Aarseth SP, Høifødt H, Helsing E, Nesheim S, Totlandsdal K, 2004 13 [ http://www.helsetilsynet.no/upload/ Publikasjoner/tilsynsmelding/annual-supervision-report-2004.pdf ]
7. Drug abuse tests important part of preventive measures against narcotics. With testing drug abuse can be identified early in the workplace. Hermansson O, Beck O, Westregård A, Brunes M, Läkartidningen 2010 107 46 2878 2880
8. Oral Fluid reveals more heroin use than previously believed, according to Quest Diagnostics Drug Testing Index. Quest Diagnostics, [ http://www. questdiagnostics.com/dms/Documents/DTI-Reports/2011-01-31-DTI.pdf ]
9. The U.S. mandatory guidelines for federal workplace drug testing programs: current status and future considerations. Bush DM, Forensic Sci Int 2007 174 2-3 111 119 17434274
10. Alternative specimens for workplace drug testing. Caplan Y, Goldberger B, J Anal Toxicol 2001 25 5 396 399 10.1093/jat/25.5.396 11499896
11. Use of alcohol and drugs by Norwegian employees: a pilot study using questionnaires and analysis of oral fluid. Gjerde H, Christophersen A, Moan I, Yttredal B, Walsh J, Normann P, Mørland J, J Occup Med Toxicol 2010 5 13 1 8 20181140
12. Female surgeons' alcohol use: a study of a national sample of norwegian doctors. Rosta J, Aasland O, Alcohol Alcohol 2005 40 436 440 10.1093/alcalc/agh186 16043434
13. Alcohol & drug use among employees in the private business sector in Norway. Nesvåg S, Lie T, Nordic Stud Alcohol Drugs 2004 21 2 91 109
14. Results of workplace drug testing in Norway. Lund H, Bogstrand S, Christophersen A, Norsk Epidemiologi 2011 21 1 55 59
15. Skretting A, Storvoll E, Developments in the Field of Alcohol and Drugs. Background Information for the Government's Report on Alcohol and Drugs Policy to the Storting Oslo: Norwegian Institute for Alcohol and Drug Research 2011
16. Can the use of psychoactive drugs in the general adult population be estimated based on data from a roadside survey of drugs and driving? Gjerde H, Normann P, Mørland J, Norsk Epidemiologi 2011 21 1 49 54
17. Storvoll E, Rossow I, Moan I, Norström T, Scheffels J, Lauritzen G, Harms Related to Use of Alcohol, Drugs and Tobacco Oslo: Norwegian Institute for Alcohol and Drug Research 2010
18. Using biological samples in epidemiological research on drugs of abuse. Gjerde H, Øiestad E, Christophersen A, Norsk Epidemiologi 2011 21 1 5 14
19. Determination of ethylglucuronide in oral fluid by ultra-performance liquid chromatography-tandem mass spectrometry. Hegstad S, Johnsen L, Mørland J, Christophersen A, J Anal Toxicol 2009 33 4 204 207 10.1093/jat/33.4.204 19470222
20. Drug testing in oral fluid-evaluation of sample collection devices. Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi K, Lillsunde P, J Anal Toxicol 2008 32 6 393 401 10.1093/jat/32.6.393 18652744
21. An automated alcohol dehydrogenase method for ethanol quantification in urine and whole blood. Kristoffersen L, Smith-Kielland A, J Anal Toxicol 2005 29 5 387 389 10.1093/jat/29.5.387 16105266
22. Elimination times for drugs of abuse in oral fluid from patients with high and repeated intake-case examples. Oiestad E, Vindenes V, Enger A, Johansen U, Hjelmeland K, Christophersen A, Program and Abstracts of the Joint Meeting of the Society of Forensic Toxicologists and the International Association of Forensic Toxicologists: 25-30 September, 2011; San Francisco, CA San Francisco, CA: SOFT & TIAFT, Lemos NP, Gordon AM, Isenschmid DS, Spiehler VR, Huestis MA, Marinetti L, Gerostamoulos D, Ropero-Miller J, Stout PR, 2011 27 [ http://www.tiaft.org/socialmediauploads/2011-soft-tiaft.pdf ]
23. Review: pharmacokinetics of illicit drugs in oral fluid. Drummer OH, Forensic Sci Int 2005 150 2-3 133 142 15944053
24. Prescription misuse and other risk factors for substance use disorders among student nurses: Results of a pilot test using the shunt self-survey for nurses. Scimeca P, [ http://www.unbecominganurse.org/SHUNT-Student-Pilot-Sample. pdf ]
25. The prevalence of alcohol, cigarette and illicit drug use and problems among dentists. Kenna G, Wood M, J Am Dent Assoc 2005 136 1023 1032 10.14219/jada.archive.2005.0297 16060477
26. Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey. Van der Linden T, Silverans P, Verstraete A, Drug Test Anal 2014 6 1-2 137 142 23939912
27. Ethyl glucuronide concentrations in oral fluid, blood, and urine after volunteers drank 0.5 and 1.0 g/kg doses of ethanol. Høiseth G, Yttredal B, Karinen R, Gjerde H, Mørland J, Christophersen A, J Anal Toxicol 2010 34 6 319 324 10.1093/jat/34.6.319 20663284
28. Horverak O, Bye E, The Norwegian Drinking Pattern. A Study Based on Analyses of Survey Data from 1973-2004 Oslo: Norwegian Institute for Alcohol and Drug Research 2007
29. Detection times of drugs of abuse in blood, urine, and oral fluid. Verstraete AG, Ther Drug Monit 2004 26 2 200 205 10.1097/00007691-200404000- 00020 15228165
30. Norwegian roadside survey of alcohol and drug use by drivers (2008-2009). Gjerde H, Christophersen A, Normann P, Assum T, Øiestad E, Mørland J, Traffic Inj Prev 2012 14 5 443 452
31. The utility of drug testing in epidemiological research: results from a general population survey. Fendrich M, Johnson T, Wislar J, Hubbell A, Spiehler V, Addiction 2004 99 2 197 208 10.1111/j.1360-0443.2003.00632.x 14756712
32. Validity of adolescent self-report of substance use. Williams R, Nowatzki N, Subst Use Misuse 2005 40 299 311 10.1081/JA-200049327 15776978
33. Comparison of drug concentrations in blood and oral fluid collected with the Intercept® sampling device. Gjerde H, Mordal J, Christophersen A, Bramness J, Mørland J, J Anal Toxicol 2010 34 4 204 209 10.1093/jat/34.4.204 20465866